Greystone Associates Analyzes the Economic, Demographic and Pain Management Factors Driving Demand for Patient-Friendly Formulations

Transdermal drug delivery has gained a solid market position in a few specialty markets, owing to the unique advantages it provides in selected therapeutic applications. Now these advantages are beginning to inure to a class of conditions that are particularly well-suited to the major benefits of transdermal drug administration.

Applied Data Research Analyzes the Market and Competitive Factors Driving the Growth of Transdermal Prescription Pain Patches and Gels

New Research by Applied Data Research Analyzes the Therapeutic and Economic Impact of generic drugs in alternative drug delivery systems

(Nashua, NH) - As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families. Because it has the potential to improve drug therapy compliance, transdermal delivery addresses a key healthcare issue – one that is particularly problematic in aging populations and developing economies.

New Survey by Greystone Associates Analyzes Demand Factors for Transdermal Patches.

Greystone Associates Analyzes Therapeutic Sectors and Growth Prospects

Greystone Associates Finds Future Demand Linked to Patient Acceptance

Greystone Associates Report Analyzes Growth Factors, Technology Drivers

Greystone Associates Analyzes the Impact of Generics, Post-launch Complications, and New Transdermal Products on Demand and Revenue.

As patients live longer and are diagnosed with chronic and often debilitating ailments, caregivers and managed care organizations are bracing for a dramatic increase in self-administration of drug therapies in non-traditional settings for a number of conditions. Because non-compliance with prescription protocols is a major healthcare concern, particularly in older patients taking several prescribed drugs, transdermal patches continue to attract attention from both drug developers and drug packaging designers.